FDA clears start of investigator-sponsored trial of Kiadis' off-the-shelf NK cell therapy for AML Feb. 27, 2020
Sitagliptin for preventing aGvHD following myeloablative allogeneic transplantation shows promise Feb. 27, 2020
RSS